Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 31, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
CoagulopathyLiver Transplantation
Interventions
DIAGNOSTIC_TEST

Hemosonics Quantra coagulation monitor

There is no categorisation or allocation of any subject to any intervention vs non-intervention group. Blood sampling and the addition of a Quantra coagulation test is the only 'intervention', and the sampling protocol is identical for all subjects. Post-testing treatment of all subjects is as per established routine and Quantra results will not be used by clinical team.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

HemoSonics LLC

INDUSTRY

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT04274699 - Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation | Biotech Hunter | Biotech Hunter